SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 598 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415,646 | +20782200.0% | 1,959 | -89.3% | 0.00% | – |
| Q2 2023 | $2 | -100.0% | 18,271 | +146.8% | 0.00% | -100.0% |
| Q4 2021 | $926,000 | -19.8% | 7,404 | +9.9% | 0.01% | 0.0% |
| Q3 2021 | $1,155,000 | -31.2% | 6,739 | -36.6% | 0.01% | -30.0% |
| Q2 2021 | $1,680,000 | +4.2% | 10,630 | -3.0% | 0.01% | 0.0% |
| Q1 2021 | $1,613,000 | -18.6% | 10,954 | +1.0% | 0.01% | -23.1% |
| Q4 2020 | $1,982,000 | – | 10,847 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |